Range of eligible clients: CDEC mentioned the uncertainty in the quantity of patients with moderately significant to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical gurus consulted by CADTH indicated that some patients who are categorized as obtaining delicate or reasonable disorder may have a serious bleeding phenotype, https://rafaeljlkji.blogmazing.com/35105375/details-fiction-and-hemgenix